Meling officially landed on the new third board on February 24, 2016. At present, it is carrying out strategic transformation: from “cryogenic equipment field” to “biomedical field”, from “terminal product manufacturer” to “product + service provider”, from “technology-oriented” to “technology-based, product-based, market-oriented and user-centered”
Showing all 8 results






